KMC Speciality Hospitals (India) Ltd.
Snapshot View

57.25 -1.80 ▼-3.1%

25 May 2022, 04:01:00 PM
Volume: 33,504

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.kauveryhospital.com
Market Cap 923.06 Cr.
Enterprise Value(EV) 936.87 Cr. 2021-09
Financial Indicators
Earnings per share (EPS) 1.52 Trailing Twelve Months Ending 2021-12
Price-Earning Ratio (PE) 37.29 Trailing Twelve Months Ending 2021-12
Industry PE 38.69 Trailing Twelve Months Ending 2021-12
Book Value / Share 5.06 Trailing Twelve Months Ending 2021-12
Price to Book Value 11.18 Calculated using Price: 56.60
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 16.31 Cr. 163,085,000 Shares
FaceValue 1
Company Profile

KMC Speciality Hospital (I), formerly Seahorse Hospitals Ltd is a renowned hospital situated in Trichy was incorporated in 1999. The hospital boasts of a 24-hour cardiac care with facilities comparable to metropolitan cities like Chennai, Bangalore, Mumbai, etc.

KMC hospital, in its decennial year of operations has added numerous feathers to its cap.From a humble beginning of 30 beds in 1999 it has come a long way to 400 beds by acquiring Seahorse Hospital. The number of doctors in the hospital has grown from 10 to 100 and the satff members have grown to over 1000.

Seahorse hospital management was taken over by KMC by the end of February 2008 .Now all the procedural formalities have been completed and hence forth it will be called as KMC Speciality Hospital, has came into effect from December 12 2008. KMC Group of Hospitals is planning to invest further Rs.10 crore to upgrade all the existing facilities.

To reaffirm the high level of healthcare which they are providing, they have started the accreditaion process for National Accreditaion Board for Hospital (NABH) and for National Accreditaion Board for Laboratories (NABL). The hospital has full time consultants in all the basic specialties. Especially Obstetrics & Gynaecology, Paediatrics, Cardiology, ENT, Dental, Joint Replacement, Plastic Surgery, Neurology, diabetology, etc. The hospital will be starting infertility Management very soon.

KMC Speciality Hospitals (I)  has an out patient department exclusively like Coronary artery disease clinic, Pediatric Cardiology, Vascular Heart disease clinic, Arrhythmia Clinic, Cardiovascular surgery department.

KMC Speciality Hospitals (I) , offers a comprehensive cardiac health check up scheme called 'Healthy Heart'.This includes a detailed cardiac examination by physicians and cardiologist followed by a wide range of investigations that include blood tests, to check for diabetes, high cholesterol and kidney disease, urine tests, ECG, Echo 2D etc.

Services offered by the company :

Specialties services:

  • Cardiology
  • Accident & Emergency
  • Diabetology
  • Dentistry
  • ENT
  • Orthopaedics
  • Obstetrics & Gynaecology
  • Paediatrics and Neonatology
  • Gastroenterology
  • Laproscopic Surgery
  • Opthalmology
  • Psychiatry
  • Rheumatology
  • General medicine
  • Urology and Nephrology

Other services:

  • Ambulance Services 
  • Blood Bank 
  • Labortatory
  • Pharmacy
  • Radiology

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-3.05%
1 Week
-5.29%
1 Month
-15.31%
3 Month
+1.24%
6 Month
-9.49%
1 Year
+43.30%
2 Year
+289.19%
5 Year
+294.83%
10 Year
+3171.43%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 7.24 -2.52 1.22 27.24 28.60 24.43 24.78 26.17 22.42
Return on Capital Employed (%) 17.95 2.37 8.53 23.92 34.73 28.63 29.11 33.09 25.85
Return on Assets (%) 2.87 -0.88 0.38 10.63 17.14 16.30 16.40 17.24 12.81

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2021-09* Rs. Cr.
Shh. Funds 13 10 10 13 24 30 39 51 63 74
Non Curr. Liab. 15 14 12 6 -1 7 5 17 44 28
Curr. Liab. 6 9 9 10 10 12 12 12 13 14
Minority Int.
Equity & Liab. 34 33 31 29 33 49 56 80 120 117
Non Curr. Assets 32 31 28 27 29 41 44 62 93 82
Curr. Assets 3 3 3 3 4 8 13 18 26 35
Misc. Exp. not W/O
Total Assets 34 33 31 29 33 49 56 80 120 117

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2021-12 Rs. Cr. TTM
Net Sales 29 32 36 43 55 71 82 96 103 133
Other Income 0 3 0 1 0 0 2 1 3 2
Total Income 29 35 37 44 55 71 84 98 105 136
Total Expenditure -23 -30 -31 -35 -42 -56 -66 -75 -80 -95
PBIDT 6 5 6 9 13 15 18 23 25 41
Interest -4 -2 -2 -2 -1 -1 -1 -1 -1 -1
Depreciation -1 -4 -4 -3 -3 -4 -4 -5 -6 -7
Taxation 0 1 -1 -3 -3 -4 -5 -5 -9
Exceptional Items
PAT 1 0 0 3 5 7 9 12 13 25
Adjusted EPS 0 0 0 0 0 0 1 1 1 2

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 4 7 4 5 6 10 12 16 11 26
Cash Fr. Inv. -8 -7 -2 -1 -1 -4 -19 -9 -8 -43
Cash Fr. Finan. 4 -3 -1 -5 -5 -5 6 -5 -4 18
Net Change 0 -3 0 0 0 1 -1 1 -1 1
Cash & Cash Eqvt 3 0 0 0 0 1 0 2 1 2

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 23 May 2022
Board Meeting Intimation for Board Meeting To Be Held On 30Th May 2022
KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve the Audited financial results of the Company for the quarter and financial year ended 31st March 2022.
Thu, 12 May 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulations 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we bringto your kind notice the information received from shareholders through our RTA regarding the loss of sharecertificates and requesting for issue of duplicate share certificates as per the details attached.
Thu, 05 May 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulations 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we provide herewith the information regarding issue of duplicate share certificates as per the details attached.

Technical Scans View Details

Wed, 25 May 2022
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
High Decrease 1 Month High Decrease 1 Month
High Increase 1 Year High Increase 1 Year

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 218,615.41 911.15 +0.1%
Divi's Laboratories Ltd. 93,410.43 3,518.70 -3.9%
Cipla Ltd. 78,373.92 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. 71,774.48 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. 50,694.88 3,525.75 -2.9%
Gland Pharma Ltd. 45,552.31 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. 44,253.16 2,615.30 +0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-12 33.92 911.15 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 31.55 3,518.70 -3.9%
Cipla Ltd. Consolidated 2022-03 31.14 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.89 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-12 44.73 3,525.75 -2.9%
Gland Pharma Ltd. Consolidated 2022-03 37.59 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. Consolidated 2021-12 36.30 2,615.30 +0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-12 4.23 911.15 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 7.96 3,518.70 -3.9%
Cipla Ltd. Consolidated 2022-03 3.76 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-12 9.16 3,525.75 -2.9%
Gland Pharma Ltd. Consolidated 2022-03 6.36 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. Consolidated 2021-12 6.84 2,615.30 +0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 911.15 +0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,518.70 -3.9%
Cipla Ltd. Consolidated 2021-03 0.10 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,525.75 -2.9%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,615.30 +0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 911.15 +0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,518.70 -3.9%
Cipla Ltd. Consolidated 2021-03 14.13 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,525.75 -2.9%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,615.30 +0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 911.15 +0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,518.70 -3.9%
Cipla Ltd. Consolidated 2021-03 14.13 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,525.75 -2.9%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,615.30 +0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 911.15 +0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,518.70 -3.9%
Cipla Ltd. Consolidated 2021-03 19,159.59 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,525.75 -2.9%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,615.30 +0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 911.15 +0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,518.70 -3.9%
Cipla Ltd. Consolidated 2021-03 2,401.30 971.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,312.70 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,525.75 -2.9%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,767.85 -3.6%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,615.30 +0.9%